
Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.
Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.
Your daily dose of the clinical news you may have missed.
Less than a quarter of persons with cirrhosis who are diagnosed with osteoporosis are started on treatment, reported researchers.
Your daily dose of the clinical news you may have missed.
The new guideline underscores the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with ALD.
Semaglutide was associated with a lower risk of first-time and recurrent suicidal ideations in patients with obesity or overweight or T2D, according to new study.
Angela Fitch, MD, president of the Obesity Medicine Association, details what to look forward to this year in terms of obesity management.
Data from recent Austrian study suggest that sex should be considered when determining screening age for colorectal cancer, reported authors.
Your daily dose of the clinical news you may have missed.
President of the Obesity Medicine Association discusses how clinician perspectives on obesity and obesity treatment are changing for the better.
Adults who said they always added extra salt to their food had an 11% higher risk for developing CKD compared with those who never or only rarely added salt, according to new research.
Findings underscore the importance of preventive measures and management of risk factors associated with CKD in adolescents with elevated BMI, report researchers.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Angela Fitch, MD, discusses the importance of clinician education in addressing obesity with patients.
President of the Obesity Medicine Association discusses a recent joint statement from the OMA and 4 other organizations calling for inclusion of patients with obesity in drug research.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
Angela Fitch, MD, president of the Obesity Medicine Association discusses key pharmaceutical and research developments in obesity medicine in 2023.
Your daily dose of the clinical news you may have missed.
The US FDA approved expanded indications for bempedoic acid and bempedoic acid plus ezetimibe for primary hyperlipidemia.
Your daily dose of the clinical news you may have missed.
Your daily dose of the clinical news you may have missed.
The task force recommends clinicians provide or refer children and adolescents with a high BMI to intensive, comprehensive behavioral interventions.
Your daily dose of the clinical news you may have missed.
Study participants randomized to placebo for 1 year after 36 weeks on tirzepatide had mean weight regain of 14% vs augmented loss among those who continued on the medication.
Your daily dose of the clinical news you may have missed.
Higher intake of omega-3 polyunsaturated fatty acids may reduce the risk for cardiovascular disease in persons with a family history of CVD.